Pliant Therapeutics Inc
NASDAQ:PLRX 4:00:00 PM EDT
Market Cap (Intraday) | 1.62B |
Current PE | N/A |
Forward PE | N/A |
2yr Forward PE | N/A |
10-Day MA | $28.31 |
50-Day MA | $29.57 |
200-Day MA | $21.17 |
Pliant Therapeutics Inc Stock, NASDAQ:PLRX
260 Littlefield Avenue, South San Francisco, California 94080
United States of America
Phone: +1.650.481.6770
Number of Employees: 124
Description
Pliant Therapeutics, Inc. engages in the discovery and development of therapies for fibrotic diseases. It offers product discovery engine. The company is pursuing drug development programs for a range of fibrotic diseases, focusing on tissue-specific integrin modulation and TGF-Ã?Å?1 signaling inhibition. The company was founded by Bradley Backes, Bill De Grado, Hal Chapman, and Dean Sheppard in June 2015 and is headquartered in South San Francisco, CA.